Showing posts with label
DNAediting
.
Show all posts
Showing posts with label
DNAediting
.
Show all posts
Friday, May 24, 2024
Editas Medicine and CRISPR Therapeutics are both gene-editing companies that focus on developing therapies using CRISPR-Cas9 technology.
›
Let’s explore their differences and where they stand in terms of DNA editing technology: Editas Medicine : Market Cap : Approximately $4...
Wednesday, May 1, 2024
Ginkgo Bioworks is building out their BioManufacturing Foundry platform which mimics the building of semiconductor foundries of yester year!
›
78.63% of #GinkgoBioworks ( $DNA ) stock is owned by #Institutional #investors . Here are some of the major institutional shareholders: ...
1 comment:
›
Home
View web version
